GleamWall
中文EN

ICUI ICU MEDICAL INC/DE

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 883984 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-5.9%
TTM net income YoY919.5%
TTM EPS YoY846.9%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—

Margins

Gross margin40.3%
Operating margin5.1%
Net margin2.8%
FCF margin9.6%
EBITDA margin11.2%

Returns

ROE2.8%
ROA1.5%
ROIC (approx.)3.6%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets44.4%
Debt / equity0.53x
Current ratio2.37x
Interest coverage1.41x

Cash quality & payout

Operating cash flow / net income4.63x
Accruals ratio-5.4%
Payout ratio—
Capex / revenue3.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.23B$2.38B
Cost of revenue$1.41B$1.56B
Gross profit$822.04M$824.78M
R&D expense$87.50M$88.61M
SG&A expense$625.21M$638.76M
Operating income$42.83M$42.96M
Interest expense$93.34M$106.54M
Pretax income$4.36M-$66.01M
Income tax$2.44M$51.68M
Net income$732,000-$117.69M
EBITDA$243.57M$262.48M
EPS (basic)0.03-4.83
EPS (diluted)0.03-4.83
Weighted avg. shares (diluted)24.90M24.39M
Banking
Net interest income-$83.03M-$95.75M
Balance sheet
Cash & equivalents$307.96M$308.57M
Short-term investments—$0
Receivables$180.51M$182.83M
Inventory$615.86M$584.68M
Current assets$1.19B$1.44B
PP&E, net$451.82M$442.75M
Goodwill$1.50B$1.43B
Intangibles$633.56M$740.79M
Total assets$4.05B$4.20B
Current liabilities$498.86M$556.18M
Short-term debt$18.75M$51.00M
Long-term debt$1.27B$1.53B
Total debt$1.28B$1.58B
Total liabilities$1.93B$2.24B
Shareholders' equity$2.12B$1.97B
Net debt$976.70M$1.27B
Shares outstanding24.69M24.52M
Cash flow statement
Operating cash flow$179.85M$204.03M
Capital expenditure$88.04M$79.37M
Free cash flow$91.80M$124.66M
Investing cash flow$122.23M-$88.96M
Financing cash flow-$311.52M-$55.80M
Depreciation & amortization$200.74M$219.51M
Stock-based compensation$55.76M$46.88M
Share buybacks$8.77M$11.99M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.